Article Information
History
- November 12, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Tom G Richardson1,†,
- Qin Wang1,2,3,4,5,
- Eleanor Sanderson1,6,
- Anubha Mahajan7,
- Mark I McCarthy7,
- Timothy M. Frayling8,
- Mika Ala-Korpela4,5,9,
- Allan Sniderman10,*,†,
- George Davey Smith1,6,*,† and
- Michael V Holmes1,2,11,*,†
- 1Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK
- 2Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
- 3Systems Epidemiology, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia
- 4Computational Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland
- 5Center for Life Course Health Research, University of Oulu, Oulu, Finland
- 6Population Health Sciences, Bristol Medical School, University of Bristol, Barley 15 House, Oakfield Grove, Bristol, BS8 2BN, UK
- 7Wellcome Centre for Human Genetics, Univ of Oxford, Oxford, OX3 7BN, UK
- 8Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, UK
- 9NMR Metabolomics Laboratory, School of Pharmacy, University of Eastern Finland, Kuopio, Finland
- 10Department of Medicine, McGill University, Montreal, Quebec, Canada
- 11Medical Research Council Population Health Research Unit at the University of Oxford, Oxford, UK
- ↵†Corresponding authors Tom Richardson: Tom.G.Richardson{at}bristol.ac.uk, George Davey Smith: KZ.Davey-Smith{at}bristol.ac.uk, Allan Sniderman: allansniderman{at}hotmail.com, Michael Holmes: michael.holmes{at}ndph.ox.ac.uk
Posted November 12, 2020.
Effects of apolipoprotein B on the lifespan and risks of major disease including type 2 diabetes: a Mendelian randomization analysis using outcomes in first-degree relatives
